USP Comment Letter: Submitted to FDA & OMB on Final Rule on Naming Guidance (2017)

Submitted February 13, 2017 - USP comments to FDA and OMB Control No. 0910-New, “Nonproprietary Naming of Biological Products” Docket No. FDA2013-D-1543.

USP-to-OMB-Final-Rule-on Naming-Guidance.pdf (2.61 MB)